cancer vaccines

Preferred Label : cancer vaccines;

MeSH definition : Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.;

MeSH synonym : vaccines, cancer; neoplasm vaccines; vaccines, tumor; vaccines, neoplasm; tumor vaccines; Tumor Vaccine; Vaccine, Tumor; Cancer Vaccine; Vaccine, Cancer;

MeSH annotation : coord IM with specific cancer histol type (IM) organ/neopl precoord (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Cancer vaccines;

Is substance : O;

Details

Origin ID

D019496;

UMLS CUI

C0376659;

ATC code(s)
- melanoma vaccine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Antineoplastic Vaccine [NCIt concept]
- Vaccine antineoplastic [ICD-11 Extension code]
Indexing information
- CIA07 adjuvant [MeSH Supplementary Concept]
- CMTWNQMNL peptide [MeSH Supplementary Concept]
- DEPDC1-294 peptide [MeSH Supplementary Concept]
- GRAMLGTHTMEVTV [MeSH Supplementary Concept]
- HER2 peptide (369-377) [MeSH Supplementary Concept]
- Immuvac [MeSH Supplementary Concept]
- MPHOSPH1-278 peptide [MeSH Supplementary Concept]
- arginyl-phenylalanyl-valyl-prolyl-aspartyl-glycyl-asparagyl-arginyl-isoleucine [MeSH Supplementary Concept]
- peptide SVYDFFVWL [MeSH Supplementary Concept]
- sipuleucel-T [MeSH Supplementary Concept]
Metaterm(s)
- oncology [CISMeF Metaterm]
Record concept(s)
- cancer vaccines [MeSH concept]
Related MeSH Supplementary Concept(s)
- AE37 vaccine [MeSH Supplementary Concept]
- ALVAC-CEA vaccine [MeSH Supplementary Concept]
- ATV-NDV-bsHN-CD28 vaccine [MeSH Supplementary Concept]
- Ad5(E1-,E2b-)-CEA(6D) vaccine [MeSH Supplementary Concept]
- Algenpantucel-L [MeSH Supplementary Concept]
- CDX 1307 [MeSH Supplementary Concept]
- CHP-HER2 vaccine [MeSH Supplementary Concept]
- CIMAvax EGF [MeSH Supplementary Concept]
- DC-MelVac [MeSH Supplementary Concept]
- DCNLGPCEA vaccine [MeSH Supplementary Concept]
- DPX-0907 [MeSH Supplementary Concept]
- EMD640744 [MeSH Supplementary Concept]
- FANG vaccine [MeSH Supplementary Concept]
- GVAX vaccine [MeSH Supplementary Concept]
- IDM 2101 [MeSH Supplementary Concept]
- IMA901 vaccine [MeSH Supplementary Concept]
- IMA950 [MeSH Supplementary Concept]
- IMM-101 [MeSH Supplementary Concept]
- INGN 225 [MeSH Supplementary Concept]
- L-BLP25 [MeSH Supplementary Concept]
- Lapuleucel-T [MeSH Supplementary Concept]
- Lmdd-MPFG vaccine [MeSH Supplementary Concept]
- MIS416 vaccine [MeSH Supplementary Concept]
- MUC-2-KLH vaccine [MeSH Supplementary Concept]
- MVA-BN-PAP-C1C2 vaccine [MeSH Supplementary Concept]
- MVA-BN-PRO vaccine [MeSH Supplementary Concept]
- MVA-BN-PSA-C1C2 vaccine [MeSH Supplementary Concept]
- MVAp53 vaccine [MeSH Supplementary Concept]
- NY-ESO-1-APH vaccine [MeSH Supplementary Concept]
- OCV-C01 [MeSH Supplementary Concept]
- Onyvax-P [MeSH Supplementary Concept]
- PROSTVAC [MeSH Supplementary Concept]
- PVX-410 vaccine [MeSH Supplementary Concept]
- Panvac-VF [MeSH Supplementary Concept]
- RESAN vaccine [MeSH Supplementary Concept]
- S-288310 [MeSH Supplementary Concept]
- TG4001 vaccine [MeSH Supplementary Concept]
- TG4010 [MeSH Supplementary Concept]
- TroVax [MeSH Supplementary Concept]
- UV1 vaccine [MeSH Supplementary Concept]
- amolimogene bepiplasmid [MeSH Supplementary Concept]
- belagenpumatucel L [MeSH Supplementary Concept]
- canvaxin [MeSH Supplementary Concept]
- g209-2M melanoma peptide [MeSH Supplementary Concept]
- gastrin immunogen [MeSH Supplementary Concept]
- globo H-KLH vaccine [MeSH Supplementary Concept]
- globo H-keyhole limpet hemocyanin QS-21 vaccine [MeSH Supplementary Concept]
- gp100(209-2M) vaccine [MeSH Supplementary Concept]
- leuvectin [MeSH Supplementary Concept]
- melacine [MeSH Supplementary Concept]
- p53 synthetic long peptide vaccine [MeSH Supplementary Concept]
- polyvalent melanoma cell vaccine [MeSH Supplementary Concept]
- rAd40 [MeSH Supplementary Concept]
- rF-B7.1 vaccine [MeSH Supplementary Concept]
- rF-TRICOM vaccine [MeSH Supplementary Concept]
- rV-Tricom [MeSH Supplementary Concept]
- reniale [MeSH Supplementary Concept]
- rindopepimut [MeSH Supplementary Concept]
- sialyl-Tn antigen-keyhole-limpet hemocyanin conjugate [MeSH Supplementary Concept]
- vaccinia-CEA vaccine [MeSH Supplementary Concept]
- vitespin [MeSH Supplementary Concept]
See also
- papillomavirus vaccines [MeSH Descriptor]
See also (suggested by CISMeF)
- neoplasms [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Antineoplastic Vaccine [NCIt concept]
- Vaccine antineoplastic [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients